in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance...

standard life and aviva clash over adviser charging.

source: xinhua | 2018-05-18 02:09:13 | editor: chengcheng

.

.